AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33647066 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint influence of NHB race/ethnicity and weight status
Number of subjects: 70750
Study 33647066 — intervention group
Group type: COMPARATOR
Intervention: NHBs vs NHWs
Number of subjects: 70750
Study 33181558 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop BIS-guided propofol and remifentanil titration
Number of subjects: 204
Study 33181558 — intervention group
Group type: COMPARATOR
Intervention: Manual BIS-guided propofol and remifentanil titration
Number of subjects: 204
Study 37421161 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain WM networks derived from young adults using connectome-based predictive modeling
Number of subjects: 110
Study 37421161 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual differences in WM performance
Number of subjects: 110
Study 34953469 — intervention group
Group type: EXPERIMENTAL
Intervention: RA1 mouth rinse solution (0.8% proanthocyanidin-enriched extract from Rumex acetosa)
Number of subjects: 35
Study 34953469 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 35
Study 32446304 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzydamine hydrochloride gargle (15 mL of 0.15% solution)
Number of subjects: 72
Study 32446304 — intervention group
Group type: COMPARATOR
Intervention: Water mouthwash (control group)
Number of subjects: 72
Study 32446304 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzydamine hydrochloride gargle
Number of subjects: 72
Study 33492774 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 90
Study 33492774 — intervention group
Group type: EXPERIMENTAL
Intervention: R-COMP
Number of subjects: 90
Study 36346807 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhera® MejoraCare Digital Program
Number of subjects: 96
Study 36346807 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 96
Study 33977739 — intervention group
Group type: EXPERIMENTAL
Intervention: ISGMS (Instantaneous Scanning Glucose Monitoring System) combined with fingertip blood glucose monitoring
Number of subjects: 110
Study 33977739 — intervention group
Group type: COMPARATOR
Intervention: Fingertip blood glucose monitoring
Number of subjects: 110
Study 34689825 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative physiotherapy
Number of subjects: 432
Study 34689825 — intervention group
Group type: COMPARATOR
Intervention: Control group (booklet alone)
Number of subjects: 432
Study 33669979 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 32
Study 33669979 — intervention group
Group type: COMPARATOR
Intervention: Placebo Dry Needling (placebo DN)
Number of subjects: 32
Study 32053298 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange (seven plasma exchanges within 14 days after randomization)
Number of subjects: 704
Study 32053298 — intervention group
Group type: COMPARATOR
Intervention: No plasma exchange (control group)
Number of subjects: 704
Study 32053298 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-dose regimen of oral glucocorticoids
Number of subjects: 704
Study 32053298 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose regimen of oral glucocorticoids
Number of subjects: 704
Study 36235824 — intervention group
Group type: EXPERIMENTAL
Intervention: Stevia-sweetened beverage
Number of subjects: 0
Study 36235824 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose and maltodextrin
Number of subjects: 0
Study 36235824 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 0
Study 33847473 — intervention group
Group type: EXPERIMENTAL
Intervention: HA+PRP
Number of subjects: 24
Study 33847473 — intervention group
Group type: COMPARATOR
Intervention: HA alone
Number of subjects: 24
Study 32773377 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about breast cancer risk reduction and breastfeeding
Number of subjects: 288
Study 32773377 — intervention group
Group type: COMPARATOR
Intervention: Breastfeeding-only messages
Number of subjects: 288
Study 36169954 — intervention group
Group type: COMPARATOR
Intervention: Standardized low-fat diet (<25% of energy intake)
Number of subjects: 199
Study 36169954 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized diet estimating PPGR
Number of subjects: 199
Study 36169954 — intervention group
Group type: COMPARATOR
Intervention: Standardized low-fat diet
Number of subjects: 199
Study 36169954 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized diet
Number of subjects: 199
Study 34395580 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Protein Solution (APS)
Number of subjects: 23
Study 34395580 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic Acid plus Triamcinolone (HAT)
Number of subjects: 23
Study 34395580 — intervention group
Group type: EXPERIMENTAL
Intervention: Both APS and HAT
Number of subjects: 23
Study 34767729 — intervention group
Group type: EXPERIMENTAL
Intervention: PP+ (Prevention Plus with caregiver goals)
Number of subjects: 73
Study 34767729 — intervention group
Group type: COMPARATOR
Intervention: PP- (Prevention Plus without caregiver goals)
Number of subjects: 73
Study 33047259 — intervention group
Group type: COMPARATOR
Intervention: RIPC
Number of subjects: 13
Study 33047259 — intervention group
Group type: COMPARATOR
Intervention: RIPCaug
Number of subjects: 13
Study 33047259 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 13
Study 32741789 — intervention group
Group type: EXPERIMENTAL
Intervention: Mismatch (Mg) group using the Te.M.P.O. application
Number of subjects: 30
Study 32741789 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRLg) group using the Te.M.P.O. application
Number of subjects: 30
Study 36000695 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Protector
Number of subjects: 154
Study 36000695 — intervention group
Group type: COMPARATOR
Intervention: Tracheal intubation
Number of subjects: 154
Study 33684116 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Data Capture (EDC)
Number of subjects: 1068
Study 33684116 — intervention group
Group type: COMPARATOR
Intervention: Paper-based Data Capture (PDC)
Number of subjects: 1068
Study 34038198 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% isobaric ropivacaine plus 5 µg sufentanil intrathecally (Group RS)
Number of subjects: 112
Study 34038198 — intervention group
Group type: COMPARATOR
Intervention: 0.75% isobaric ropivacaine intrathecally (Group R)
Number of subjects: 112
Study 33285665 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 50
Study 33285665 — intervention group
Group type: COMPARATOR
Intervention: Intercostal nerve block (ICNB)
Number of subjects: 50
Study 36084710 — intervention group
Group type: EXPERIMENTAL
Intervention: EE+DNG
Number of subjects: 59
Study 36084710 — intervention group
Group type: EXPERIMENTAL
Intervention: EV+DNG
Number of subjects: 59
Study 36084710 — intervention group
Group type: COMPARATOR
Intervention: DNG only
Number of subjects: 59
Study 32062566 — intervention group
Group type: EXPERIMENTAL
Intervention: Real treatment (rTMS)
Number of subjects: 43
Study 32062566 — intervention group
Group type: COMPARATOR
Intervention: Active Control
Number of subjects: 43
Study 32062566 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 43
Study 35342059 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 212
Study 35342059 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological interventions
Number of subjects: 212
Study 35342059 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Number of subjects: 212
Study 32297259 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track surgery nursing program
Number of subjects: 84
Study 32297259 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 84
Study 35652434 — intervention group
Group type: EXPERIMENTAL
Intervention: Two daily applications of 1 h each
Number of subjects: 86
Study 35652434 — intervention group
Group type: EXPERIMENTAL
Intervention: A 2-h single application
Number of subjects: 86
Study 34152699 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiltse approach
Number of subjects: 780
Study 34152699 — intervention group
Group type: COMPARATOR
Intervention: Conventional open approach
Number of subjects: 780
Study 32980290 — intervention group
Group type: EXPERIMENTAL
Intervention: Bempedoic acid (180 mg once daily for 12 to 52 weeks)
Number of subjects: 3621
Study 32980290 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once daily for 12 to 52 weeks)
Number of subjects: 3621
Study 32980290 — intervention group
Group type: EXPERIMENTAL
Intervention: Bempedoic acid
Number of subjects: 3621
Study 32980290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3621
Study 36040329 — intervention group
Group type: EXPERIMENTAL
Intervention: THC 10%
Number of subjects: 12
Study 36040329 — intervention group
Group type: EXPERIMENTAL
Intervention: THC/CBD 9%/9%
Number of subjects: 12
Study 36040329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 36040329 — intervention group
Group type: EXPERIMENTAL
Intervention: All cannabis products
Number of subjects: 12
Study 33155505 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet rich fibrin mixed with antibiotics (Colistin, Ciprofloxacin‐Colistin combination, Tobramycin)
Number of subjects: 10
Study 33155505 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet rich fibrin mixed with antibiotics
Number of subjects: 10
Study 32675314 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Continuous Positive Airway Pressure (nCPAP) administered in tertiary centers for term babies for <24 hours
Number of subjects: 1085
Study 32675314 — intervention group
Group type: COMPARATOR
Intervention: Conservative management in nontertiary centers
Number of subjects: 1085
Study 34139357 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor biofeedback (BIO)
Number of subjects: 285
Study 34139357 — intervention group
Group type: EXPERIMENTAL
Intervention: Perianal injection with bulking agents (INJ)
Number of subjects: 285
Study 34139357 — intervention group
Group type: COMPARATOR
Intervention: Enhanced medical management (EMM)
Number of subjects: 285
Study 34139357 — intervention group
Group type: COMPARATOR
Intervention: Sacral nerve electrical stimulation (SNS)
Number of subjects: 285
Study 32028397 — intervention group
Group type: EXPERIMENTAL
Intervention: High-low impact exercise program with pelvic floor muscle education and training (n=133)
Number of subjects: 260
Study 32028397 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=127)
Number of subjects: 260
Study 35683992 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g/day RMD
Number of subjects: 49
Study 35683992 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g/day RMD
Number of subjects: 49
Study 34287784 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa‐miR‐199a‐3p
Number of subjects: 39
Study 34287784 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa‐miR‐149‐3p
Number of subjects: 39
Study 34287784 — intervention group
Group type: EXPERIMENTAL
Intervention: hsa‐miR‐149‐5p
Number of subjects: 39
Study 34287784 — intervention group
Group type: COMPARATOR
Intervention: Control miR
Number of subjects: 39
Study 32335305 — intervention group
Group type: COMPARATOR
Intervention: Participants reporting no change in walking difficulty (0-4 Likert scale)
Number of subjects: 777
Study 32335305 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting one point improvement in walking ability (0-4 scale)
Number of subjects: 777
Study 32335305 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting two point improvement in walking ability (0-4 scale)
Number of subjects: 777
Study 32335305 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting one point decline in perceived walking difficulty (0-4 scale)
Number of subjects: 777
Study 32335305 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants reporting two point decline in perceived walking difficulty (0-4 scale)
Number of subjects: 777
Study 35193478 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2% CAF-MR
Number of subjects: 45
Study 35193478 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8% CAF-MR
Number of subjects: 45
Study 35193478 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4% CAF-MR
Number of subjects: 45
Study 35193478 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water)-MR
Number of subjects: 45
Study 35193478 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 34856689 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 39
Study 34856689 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 39
Study 34750035 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab (NIVO+IPI) every 3 weeks for four doses followed by Nivolumab monotherapy
Number of subjects: 108
Study 34750035 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab (NIVO+IPI)
Number of subjects: 108
Study 34750035 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 108
Study 35500098 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg atorvastatin (high-dose group)
Number of subjects: 218
Study 35500098 — intervention group
Group type: COMPARATOR
Intervention: 20 mg atorvastatin (low-dose group)
Number of subjects: 218
Study 32034790 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase III trials
Number of subjects: 252
Study 32034790 — intervention group
Group type: COMPARATOR
Intervention: Phase II trials
Number of subjects: 252
Study 35635580 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy (endocrine therapy + chemotherapy)
Number of subjects: 18437
Study 35635580 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 18437
Study 33831632 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for medication adherence
Number of subjects: 0
Study 33831632 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34143714 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential/traditional music therapy (MG group)
Number of subjects: 116
Study 34143714 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with experiential/traditional music and acupuncture (AP/MG group)
Number of subjects: 116
Study 34143714 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (CG group)
Number of subjects: 116
Study 32432448 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based training program (GB)
Number of subjects: 40
Study 32432448 — intervention group
Group type: COMPARATOR
Intervention: Multilateral training approach (MA)
Number of subjects: 40
Study 36455163 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment
Number of subjects: 0
Study 36455163 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment
Number of subjects: 0
Study 32705835 — intervention group
Group type: EXPERIMENTAL
Intervention: Hui-puncture method
Number of subjects: 100
Study 32705835 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 100
Study 35686999 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Change Program (intervention group)
Number of subjects: 294
Study 35686999 — intervention group
Group type: COMPARATOR
Intervention: Attention-control sessions (control group)
Number of subjects: 294
Study 33467421 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) - 30 inspiratory efforts twice daily, 5 days a week, at 50%, 60%, 70%, and 80% of maximum inspiratory pressure (MIP) for 4 weeks
Number of subjects: 20
Study 33467421 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 20
Study 33467421 — intervention group
Group type: COMPARATOR
Intervention: Control group (50% of MIP for 4 weeks)
Number of subjects: 20
Study 32406771 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous intraductal microwave ablation followed by metallic stenting
Number of subjects: 12
Study 35978315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticaloguard® (generic ticagrelor)
Number of subjects: 29
Study 35978315 — intervention group
Group type: COMPARATOR
Intervention: Brilique® (brand ticagrelor)
Number of subjects: 29
Study 32680841 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD prevention programme focusing on promotion of physical activity and healthy lifestyle
Number of subjects: 5761
Study 32680841 — intervention group
Group type: COMPARATOR
Intervention: Reference group from the general population in Stockholm County
Number of subjects: 5761
Study 35212300 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma injection
Number of subjects: 34
Study 35212300 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine injection
Number of subjects: 34
Study 33545749 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion
Number of subjects: 65
Study 33545749 — intervention group
Group type: COMPARATOR
Intervention: No intravenous infusion (control)
Number of subjects: 65
Study 34984830 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped classroom approach
Number of subjects: 94
Study 34984830 — intervention group
Group type: COMPARATOR
Intervention: Traditional educational approach (control)
Number of subjects: 94
Study 32285499 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention consisting of 18 sessions with activities including educational workshops, mindfulness, yoga, walking, and visits to urban gardens.
Number of subjects: 55
Study 32285499 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention
Number of subjects: 55
Study 32285499 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonlonely controls)
Number of subjects: 55
Study 32665179 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound-guided TTMPB with 20 mL of 0.25% bupivacaine
Number of subjects: 48
Study 32665179 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 48
Study 32665179 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound-guided TTMPB
Number of subjects: 48
Study 34255199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + sterile saline solution (SSL)
Number of subjects: 20
Study 34255199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + 2% chlorhexidine gel (CHX gel)
Number of subjects: 20
Study 34255199 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 20
Study 36669426 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard adjuvant radiation therapy (RT) 60Gy/30 fractions over 6 weeks
Number of subjects: 0
Study 36669426 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation
Number of subjects: 0
Study 36669426 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated radiation therapy (6 d a week)
Number of subjects: 0
Study 36669426 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of high-risk features (T3-T4 primary tumours with N2-N3 nodes along with ECE)
Number of subjects: 0
Study 34190016 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime hypertension chronotherapy (ingestion of BP-lowering medications at bedtime)
Number of subjects: 23972
Study 34190016 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime hypertension chronotherapy
Number of subjects: 23972
Study 34190016 — intervention group
Group type: COMPARATOR
Intervention: Upon-waking/morning hypertension treatment-time scheme
Number of subjects: 23972
Study 32659891 — intervention group
Group type: EXPERIMENTAL
Intervention: 30,000 IU cholecalciferol/week for six months
Number of subjects: 88
Study 32659891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 35259654 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based discrimination portrayed as legitimate
Number of subjects: 327
Study 35259654 — intervention group
Group type: COMPARATOR
Intervention: Weight-based discrimination portrayed as illegitimate
Number of subjects: 327
Study 32487024 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia Friends (a 60‐min interactive class that teaches about dementia and its effects on people's lives)
Number of subjects: 301
Study 32487024 — intervention group
Group type: COMPARATOR
Intervention: Education as usual
Number of subjects: 301
Study 34724874 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial and error (TEL)
Number of subjects: 38
Study 34724874 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-based learning (EBL)
Number of subjects: 38
Study 34724874 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic instruction (SI)
Number of subjects: 38
Study 34724874 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 38
Study 33244881 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Catheter Drainage (PCD)
Number of subjects: 543
Study 33244881 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Needle Aspiration (PNA)
Number of subjects: 543
Study 32221683 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular simulator training
Number of subjects: 305
Study 32221683 — intervention group
Group type: COMPARATOR
Intervention: Theoretical seminar
Number of subjects: 305
Study 32221683 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training (subgroup analysis)
Number of subjects: 305
Study 36261832 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letters about CVD risk
Number of subjects: 210
Study 36261832 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letters about CVD risk with Cochrane blogshots
Number of subjects: 210
Study 36261832 — intervention group
Group type: COMPARATOR
Intervention: Control group (received a letter about their CVD risk)
Number of subjects: 210
Study 34039478 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglycosides (amikacin and gentamicin) administered during CRRT.
Number of subjects: 145
Study 34039478 — intervention group
Group type: COMPARATOR
Intervention: Inappropriate reinjection threshold for gentamicin (>2 mg/L) and amikacin (>5 mg/L).
Number of subjects: 145
Study 32196898 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient oral treatment (cefixime)
Number of subjects: 117
Study 32196898 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment (cefepime)
Number of subjects: 117
Study 32196898 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient group
Number of subjects: 117